In a report released today, Patrick Wood from Morgan Stanley maintained a Hold rating on Organogenesis Holdings (ORGO – Research Report), with a price target of $6.00. The company’s shares ...

Organogenesis Holdings Inc (NASDAQ:ORGO) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 2024 revenue is $109.60 million, and the earnings are expected to ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Organogenesis Holdings (ORGO – Research Report), with a price target of $7.00. The company’s shares closed ...

2025 Adjusted EBITDA Guidance: $43.6 million to $83.2 million. Organogenesis Holdings Inc (NASDAQ:ORGO) reported a 27% increase in net revenue for the fourth quarter, exceeding the high end of ...

Organogenesis Trading Down 8.5 % Shares of Organogenesis stock opened at $5.16 on Monday. Organogenesis Holdings Inc. has a 1 year low of $2.17 and a 1 year high of $6.71. The company has a market ...

Welcome, ladies and gentlemen, to the fourth quarter and fiscal year 2024 earnings conference call for Organogenesis Holdings, Inc. At this time, all participants have been placed in listen-only ...

Read More: Earn up to $845 cash back this year just by changing how you pay at Costco! Learn more here. Operator Welcome, ladies and gentlemen, to the fourth quarter and fiscal year 2024 earnings ...

Below is a chart showing AI's trailing twelve month trading history, with the $26 strike highlighted in orange: Organogenesis Holdings Inc (Symbol: ORGO) options are showing a volume of 6,174 ...

Please standby. Welcome, ladies and gentlemen, to the Fourth Quarter and Fiscal Year 2024 Earnings Conference Call for Organogenesis Holdings, Inc. At this time, all participants have placed in ...

The business’s 50 day moving average price is $3.42 and its two-hundred day moving average price is $3.25. The company has a market capitalization of $782.27 million, a price-to-earnings ratio ...